Join Quentin Anstee (Dean of Research & Innovation and Professor of Experimental Hepatology at Newcastle University) and Lars Johansson (Chief Scientific Officer at Antaros Medical) as they discuss the complexity of chronic liver disease and cirrhosis in the upcoming webinar; Cracking Cirrhosis: Complexity of Chronic Liver Disease and Insights for Drug Development. The webinar will be live on October 15 at 17:00 CEST (16:00 BST / 11:00 EDT).
Chronic liver disease is complex. The causes are multifactorial, disease progression is slow and heterogeneous, and the pathophysiology is complicated and still not entirely understood. This has made drug development challenging, and there are still no approved treatments targeting cirrhosis.
Quentin and Lars will walk through the complexity of chronic liver disease and the resulting cirrhosis, the drivers of disease and its progression via inflammation and fibrosis, as well as the implications for drug development and patient selection. They will also cover some of the biomarkers and other tools, including magnetic resonance imaging (MRI) and positron emission tomography (PET), that can help further our disease understanding and provide valuable insights within drug development.
You can read more about the webinar and register here.
Title: Cracking Cirrhosis: Complexity of Chronic Liver Disease and Insights for Drug Development
Date and time: October 15, 17:00 CEST (16:00 BST/11:00 EDT)
Free to register and attend